Abstract:The main factors contributing to the unfavorable outcome in the clinical treatment of patients with nasopharyngeal carcinoma (NPC) patients are radiation resistance and recurrence. This study aimed to investigate the sensitivity and molecular foundation of cytokeratin 13 (CK13) in the radiotherapy of NPC. To achieve this, a human NPC cell line overexpressing CK13, HNE-3-CK13, was constructed. The effects of CK13 overexpression on cell viability and apoptosis under radiotherapy conditions were evaluated using the CCK-8 assay, immunofluorescence, and western blotting (WB). Next-generation sequencing was performed to identify the downstream genes and signaling pathways of CK13 that mediate radiotherapy response. The potential role of the candidate gene ERRFI1 in CK13-induced enhancement of radiosensitivity was investigated through rescue experiments using clone formation and WB. The effects of ERRFI1 on cell viability, cell apoptosis, cell cycle, and the related key genes were further evaluated using CCK-8, immunofluorescence, flow cytometry, quantitative polymerase chain reaction and WB. The results showed that CK13 overexpression in HNE-3 significantly inhibited cell survival under radiotherapy and promoted apoptosis marker γH2AX expression, leading to a significant increase of ERRFI1. Knockdown of ERRFI1 rescued the decreased cell viability and proliferation and the increased cell apoptosis that were caused by CK13 overexpression-mediated radiotherapy sensitization of NPC cells. In this process, EGFR, AKT, and GSK-3β were found involved. In the end, ERRFI1 was proven to inhibit expression levels of CDK1, CDK2, cyclin B1, and cyclin D1, resulting an increased G2/M cell ratio. Overexpression of CK13 enhances the radiosensitivity of NPC cells, which is characterized by decreased cell viability and proliferation and increased apoptosis. This regulation may affect the survival of HNE-3 cells by increasing the expression of ERRFI1 and activating the EGFR/Akt/GSK-3β signaling pathway, providing new potential therapeutic targets for the treatment of NPC.

Caspase-3 Gene of Mediating X Radiation Induced Apoptosis in Nasopharyngeal Carcinoma

Subcellullar Localization Of Caspase-3 Activation Correlates With Changes In Apoptotic Morphology In Molt-4 Leukemia Cells Exposed To X-Ray Irradiation

Identification of Prognostic Biomarkers for Response to Radiotherapy by DNA Microarray in Nasopharyngeal Carcinoma Patients

Expression and significance of HIF-1α,EGFR and Caspase-3 in nasopharyngeal carcinoma

Expression and Significance of HIF-1α, EGFR and Caspase-3 in Nasopharyngeal Carcinoma

[Studies on the behavioral approaches in the treatment of anorexia nervosa (author's transl)].

Ginsenoside Rg3 Sensitizes Nasopharyngeal Carcinoma Cells to Radiation by Suppressing Epithelial Mesenchymal Transition

In Vivo Empirical Study of TNF-α on Radiosensitization of Nasopharyngeal Carcinoma

The Drake Health Registry Study: cause-specific mortality experience of workers potentially exposed to beta-naphthylamine.

Current Research of Radiation-Induced Apoptosis in Nasopharyngeal Carcinoma

Inhibition of autophagy by 3-MA enhances endoplasmic reticulum stress-induced apoptosis in human nasopharyngeal carcinoma cells

RNAi-mediated Knockdown of CAIX Enhances the Radiosensitivity of Nasopharyngeal Carcinoma Cell Line, CNE-2

The increased expression of cytokeratin 13 leads to an increase in radiosensitivity of nasopharyngeal carcinoma HNE-3 cells by upregulating ERRFI1

The Preclinical Study Of Predicting Radiosensitivity In Human Nasopharyngeal Carcinoma Xenografts By F-18-Ml-10 Animal-Pet/Ct Imaging

Ionizing Radiation Promotes Advanced Malignant Traits in Nasopharyngeal Carcinoma Via Activation of Epithelial-Mesenchymal Transition and the Cancer Stem Cell Phenotype.

Antitumor and Radiosensitization Effects of a CXCR2 Inhibitor in Nasopharyngeal Carcinoma

Cancer-associated fibroblasts promote the survival of irradiated nasopharyngeal carcinoma cells via the NF-κB pathway

The combination of suicide gene therapy and radiation enhances the killing of nasopharyngeal carcinoma xenographs

The preclinical study of predicting radiosensitivity in human nasopharyngeal carcinoma xenografts by 18F-ML-10 animal- PET/CT imaging.

E2F3 Renders an Immunosuppressive Tumor Microenvironment in Nasopharyngeal Carcinoma: Involvements of the Transcription Activation of PRC1 and BIRC5.

Radiosensitivity-Related Genes and Clinical Characteristics of Nasopharyngeal Carcinoma